Alexis Peyroles
Chief Executive Officer at Ose Immunotherapeutics, Inc.
Net worth: 6 M $ as of 2024-04-29
Alexis Peyroles active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Aperana Consulting SAS | Chairman | - | - |
| Ose Immunotherapeutics, Inc. | Chief Executive Officer | - | - |
Career history of Alexis Peyroles
Former positions of Alexis Peyroles
| Companies | Position | Start | End |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Board Member | 2016-04-30 | 2022-01-15 |
| Chief Executive Officer | 2018-04-11 | 2022-01-15 | |
| Chief Operating Officer | 2016-04-30 | 2018-04-11 | |
| Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | 2008-12-31 | - |
| Sanofi-Aventis Japan | Comptroller/Controller/Auditor | 1995-12-31 | - |
| GUERBET | Comptroller/Controller/Auditor | 2004-12-31 | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 1995-12-31 | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Director of Finance/CFO | 2013-08-31 | - |
Training of Alexis Peyroles
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
| Imperial College Business School | Masters Business Admin |
Statistics
International
| France | 7 |
| United States | 2 |
| United Kingdom | 2 |
Operational
| Chief Executive Officer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GUERBET | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 6 |
|---|---|
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
| Aperana Consulting SAS | |
| Ose Immunotherapeutics, Inc. | |
| Sanofi-Aventis Japan | |
| Guerbet Imagem do Brasil Ltda. |
- Stock Market
- Insiders
- Alexis Peyroles
- Experience